FDAta by datagemba
Home
Contact
About
Account
Login
Signup
Toggle theme
Light
Dark
Auto
Warning Letters
Review Warning Letters by infraction
Regulations
Part 312: Investigational New Drug Application
Subpart A: General Provisions
21 CFR 312.7 - Promotion of investigational drugs.
21 CFR 312.7(b) - (b) Commercial distribution of an investigational new drug. A sponsor or investigator shall not ...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.7(a) - (a) Promotion of an investigational new drug. A sponsor or investigator, or any person acting on...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.7 - Promotion of investigational drugs.
Enforcement history
Companies cited for this
Warning Letters
Subpart B: Investigational New Drug Application (IND)
21 CFR 312.20 - Requirement for an IND.
21 CFR 312.20(a) - (a) A sponsor shall submit an IND to FDA if the sponsor intends to conduct a clinical investigati...
Enforcement history
Companies cited for this
Warning Letters
Subpart D: Responsibilities of Sponsors and Investigators
21 CFR 312.69 - Handling of controlled substances.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.52 - Transfer of obligations to a contract research organization.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.62 - Investigator recordkeeping and record retention.
21 CFR 312.62(b) - (b) Case histories. An investigator is required to prepare and maintain adequate and accurate ca...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.62(a) - (a) Disposition of drug. An investigator is required to maintain adequate records of the disposi...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.62(c) - (c) Record retention. An investigator shall retain records required to be maintained under this ...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.62 - Investigator recordkeeping and record retention.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.60 - General responsibilities of investigators.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.66 - Assurance of IRB review.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.50 - General responsibilities of sponsors.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 312.57 - Recordkeeping and record retention.
21 CFR 312.57(a) - (a) A sponsor shall maintain adequate records showing the receipt, shipment, or other disposition...
Enforcement history
Companies cited for this
Warning Letters
Part 50: Protection of Human Subjects
Subpart B: Informed Consent of Human Subjects
21 CFR 50.20 - General requirements for informed consent.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.24 - Exception from informed consent requirements for emergency research.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25 - Elements of informed consent.
21 CFR 50.25(c) - (c) When seeking informed consent for applicable clinical trials, as defined in 42 U.S.C. 282(j)(...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25 - Elements of informed consent.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25(a) - (a) Basic elements of informed consent. In seeking informed consent, the following information s...
21 CFR 50.25(a)(2) - (2) A description of any reasonably foreseeable risks or discomforts to the subject.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25(a)(4) - (4) A disclosure of appropriate alternative procedures or courses of treatment, if any, that migh...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25(a)(5) - (5) A statement describing the extent, if any, to which confidentiality of records identifying th...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25(a)(6) - (6) For research involving more than minimal risk, an explanation as to whether any compensation ...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.25(b) - (b) Additional elements of informed consent. When appropriate, one or more of the following elem...
21 CFR 50.25(b)(3) - (3) Any additional costs to the subject that may result from participation in the research.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.27 - Documentation of informed consent.
21 CFR 50.27(a) - (a) Except as provided in § 56.109(c), informed consent shall be documented by the use of a writt...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.27 - Documentation of informed consent.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.27(b) - (b) Except as provided in § 56.109(c), the consent form may be either of the following:
21 CFR 50.27(b)(1) - (1) A written consent document that embodies the elements of informed consent required by § 50.25...
Enforcement history
Companies cited for this
Warning Letters
Subpart D: Additional Safeguards for Children in Clinical Investigations
21 CFR 50.52 - Clinical investigations involving greater than minimal risk but presenting the prospect of direct...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.53 - Clinical investigations involving greater than minimal risk and no prospect of direct benefit to ...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.51 - Clinical investigations not involving greater than minimal risk.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.55 - Requirements for permission by parents or guardians and for assent by children.
21 CFR 50.55(g) - (g) When the IRB determines that assent is required, it must also determine whether and how assen...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 50.55(a) - (a) In addition to the determinations required under other applicable sections of this subpart D,...
Enforcement history
Companies cited for this
Warning Letters
Part 56: Institutional Review Boards
Subpart A: General Provisions
21 CFR 56.104 - Exemptions from IRB requirement.
21 CFR 56.104(c) - (c) Emergency use of a test article, provided that such emergency use is reported to the IRB with...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.103 - Circumstances in which IRB review is required.
21 CFR 56.103(a) - (a) Except as provided in §§ 56.104 and 56.105, any clinical investigation which must meet the re...
Enforcement history
Companies cited for this
Warning Letters
Subpart B: Organization and Personnel
21 CFR 56.107 - IRB membership.
21 CFR 56.107(a) - (a) Each IRB shall have at least five members, with varying backgrounds to promote complete and a...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.107(f) - (f) An IRB may, in its discretion, invite individuals with competence in special areas to assist ...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.107(e) - (e) No IRB may have a member participate in the IRB's initial or continuing review of any project...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.107 - IRB membership.
Enforcement history
Companies cited for this
Warning Letters
Subpart C: IRB Functions and Operations
21 CFR 56.109 - IRB review of research.
21 CFR 56.109(c) - (c) An IRB shall require documentation of informed consent in accordance with § 50.27 of this cha...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.109(h) - (h) When some or all of the subjects in a study are children, an IRB must determine that the rese...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.109(e) - (e) An IRB shall notify investigators and the institution in writing of its decision to approve o...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.109(f) - (f) An IRB shall conduct continuing review of research covered by these regulations at intervals ...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.109(b) - (b) An IRB shall require that information given to subjects as part of informed consent is in acc...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.111 - Criteria for IRB approval of research.
21 CFR 56.111(c) - (c) In order to approve research in which some or all of the subjects are children, an IRB must d...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.111 - Criteria for IRB approval of research.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.110 - Expedited review procedures for certain kinds of research involving no more than minimal risk, an...
21 CFR 56.110(b) - (b) An IRB may use the expedited review procedure to review either or both of the following:
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.108 - IRB functions and operations.
21 CFR 56.108(b) - (b) Follow written procedures for ensuring prompt reporting to the IRB, appropriate institutional...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.108(c) - (c) Except when an expedited review procedure is used (see § 56.110), review proposed research at...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.108 - IRB functions and operations.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.108(a) - (a) Follow written procedures:
21 CFR 56.108(a) - (a) Follow written procedures:
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.108(a)(1) - (1) For conducting its initial and continuing review of research and for reporting its findings a...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.113 - Suspension or termination of IRB approval of research.
Enforcement history
Companies cited for this
Warning Letters
Subpart D: Records and Reports
21 CFR 56.115 - IRB records.
21 CFR 56.115(b) - (b) The records required by this regulation shall be retained for at least 3 years after completi...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.115 - IRB records.
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.115(a) - (a) An institution, or where appropriate an IRB, shall prepare and maintain adequate documentatio...
21 CFR 56.115(a) - (a) An institution, or where appropriate an IRB, shall prepare and maintain adequate documentatio...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.115(a)(1) - (1) Copies of all research proposals reviewed, scientific evaluations, if any, that accompany the...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.115(a)(2) - (2) Minutes of IRB meetings which shall be in sufficient detail to show attendance at the meeting...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.115(a)(5) - (5) A list of IRB members identified by name; earned degrees; representative capacity; indication...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 56.115(a)(6) - (6) Written procedures for the IRB as required by § 56.108 (a) and (b).
Enforcement history
Companies cited for this
Warning Letters
Part 58: Good Laboratory Practice for Nonclinical Laboratory Studies
Subpart B: Organization and Personnel
21 CFR 58.33 - Study director.
21 CFR 58.33(c) - (c) Unforeseen circumstances that may affect the quality and integrity of the nonclinical laborat...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 58.35 - Quality assurance unit.
21 CFR 58.35(b) - (b) The quality assurance unit shall:
21 CFR 58.35(b)(5) - (5) Determine that no deviations from approved protocols or standard operating procedures were ma...
Enforcement history
Companies cited for this
Warning Letters
Subpart G: Protocol for and Conduct of a Nonclinical Laboratory Study
21 CFR 58.130 - Conduct of a nonclinical laboratory study.
21 CFR 58.130(e) - (e) All data generated during the conduct of a nonclinical laboratory study, except those that ar...
Enforcement history
Companies cited for this
Warning Letters
21 CFR 58.130(a) - (a) The nonclinical laboratory study shall be conducted in accordance with the protocol.
Enforcement history
Companies cited for this
Warning Letters
Subpart J: Records and Reports
21 CFR 58.190 - Storage and retrieval of records and data.
21 CFR 58.190(a) - (a) All raw data, documentation, protocols, final reports, and specimens (except those specimens ...
Enforcement history
Companies cited for this
Warning Letters